CIBC World Market’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$235M Buy
255,820
+1,734
+0.7% +$1.76M 0.38% 58
2025
Q4
$273M Buy
254,086
+15,772
+7% +$15.1M 0.44% 52
2025
Q3
$182M Buy
238,314
+49,634
+26% +$36.9M 0.33% 64
2025
Q2
$147M Buy
188,680
+4,602
+3% +$3.58M 0.29% 66
2025
Q1
$152M Sell
184,078
-15,419
-8% -$12.8M 0.33% 67
2024
Q4
$154M Buy
199,497
+19,905
+11% +$16.5M 0.32% 68
2024
Q3
$159M Buy
179,592
+16,306
+10% +$14.7M 0.33% 67
2024
Q2
$148M Buy
163,286
+17,592
+12% +$14.1M 0.34% 61
2024
Q1
$113M Buy
145,694
+18,070
+14% +$12.9M 0.27% 66
2023
Q4
$74.4M Buy
127,624
+1,724
+1% +$1.01M 0.19% 87
2023
Q3
$67.6M Buy
125,900
+15,097
+14% +$7.78M 0.22% 84
2023
Q2
$52M Buy
110,803
+16,873
+18% +$7.08M 0.17% 97
2023
Q1
$32.3M Sell
93,930
-39,431
-30% -$13.3M 0.11% 129
2022
Q4
$48.8M Sell
133,361
-651
-0.5% -$231K 0.17% 98
2022
Q3
$43.3M Sell
134,012
-4,601
-3% -$1.46M 0.17% 100
2022
Q2
$44.9M Buy
138,613
+14,157
+11% +$4.25M 0.16% 98
2022
Q1
$35.6M Buy
124,456
+2,262
+2% +$582K 0.11% 117
2021
Q4
$33.8M Buy
122,194
+49,137
+67% +$12.5M 0.1% 132
2021
Q3
$16.9M Buy
73,057
+8,128
+13% +$2.01M 0.06% 180
2021
Q2
$14.9M Sell
64,929
-1,078
-2% -$217K 0.04% 210
2021
Q1
$12.3M Sell
66,007
-2,933
-4% -$574K 0.04% 219
2020
Q4
$11.6M Sell
68,940
-651
-0.9% -$97.2K 0.04% 215
2020
Q3
$10.3M Sell
69,591
-14,415
-17% -$2.23M 0.04% 204
2020
Q2
$13.8M Buy
84,006
+22,903
+37% +$3.52M 0.06% 163
2020
Q1
$8.48M Sell
61,103
-25,869
-30% -$3.55M 0.04% 190
2019
Q4
$11.4M Buy
86,972
+3,052
+4% +$354K 0.05% 190
2019
Q3
$9.38M Buy
83,920
+45,522
+119% +$5.07M 0.04% 191
2019
Q2
$4.25M Sell
38,398
-232,437
-86% -$27.4M 0.02% 323
2019
Q1
$35.1M Buy
270,835
+159,252
+143% +$19.4M 0.16% 93
2018
Q4
$12.9M Buy
111,583
+27,744
+33% +$3.1M 0.07% 165
2018
Q3
$9M Sell
83,839
-85,517
-50% -$8.55M 0.04% 208
2018
Q2
$14.5M Sell
169,356
-75,762
-31% -$6.22M 0.06% 157
2018
Q1
$19M Buy
245,118
+117,577
+92% +$9.47M 0.08% 127
2017
Q4
$10.8M Buy
127,541
+8,477
+7% +$721K 0.05% 140
2017
Q3
$10.2M Sell
119,064
-239,525
-67% -$19.6M 0.05% 142
2017
Q2
$29.5M Buy
358,589
+317,354
+770% +$25.9M 0.13% 89
2017
Q1
$3.47M Sell
41,235
-49,818
-55% -$3.99M 0.01% 327
2016
Q4
$6.7M Buy
91,053
+26,193
+40% +$1.95M 0.02% 195
2016
Q3
$5.21M Buy
64,860
+2,688
+4% +$215K 0.02% 202
2016
Q2
$4.9M Buy
62,172
+31,685
+104% +$2.39M 0.02% 192
2016
Q1
$2.19M Buy
30,487
+5,563
+22% +$421K 0.01% 290
2015
Q4
$2.1M Sell
24,924
-7,227
-22% -$600K 0.01% 325
2015
Q3
$2.69M Buy
32,151
+72
+0.2% +$6.08K 0.01% 254
2015
Q2
$2.68M Sell
32,079
-23,451
-42% -$1.79M 0.01% 283
2015
Q1
$4.03M Buy
55,530
+5,044
+10% +$359K 0.02% 196
2014
Q4
$3.48M Sell
50,486
-17,924
-26% -$1.21M 0.01% 215
2014
Q3
$4.44M Sell
68,410
-46,342
-40% -$2.93M 0.02% 160
2014
Q2
$7.13M Sell
114,752
-32,429
-22% -$1.93M 0.02% 113
2014
Q1
$8.66M Buy
147,181
+1,355
+0.9% +$75.6K 0.03% 84
2013
Q4
$7.44M Sell
145,826
-77,530
-35% -$3.88M 0.03% 95
2013
Q3
$11.2M Buy
223,356
+7,325
+3% +$383K 0.05% 63
2013
Q2
$10.6M Buy
+216,031
New +$11.8M 0.05% 60

Other funds holding LLY

CIBC World Market's LLY Position: Q1 2026 in Review

CIBC World Market increased its Eli Lilly (LLY) stake by 0.68% in Q1 2026, buying an estimated $1.76M and bringing the position to 255,820 shares worth $235M. The position accounts for 0.38% of the portfolio, ranked #58.

CIBC World Market first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $273M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • CIBC World Market held 255,820 shares of Eli Lilly worth $235M as of Q1 2026.
  • CIBC World Market bought 1,734 Eli Lilly shares in Q1 2026, an estimated $1.76M.
  • Eli Lilly made up 0.38% of CIBC World Market's portfolio in Q1 2026, its #58 holding.
  • CIBC World Market first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • CIBC World Market's Eli Lilly position peaked at $273M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.